Watts Ryan J.

President and CEO, DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Jan 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$581K
Net Open-Market Flow
-$581K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2026Sell(S)35K$16.50$581K297K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001724310-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: